Elevated CEA is associated with worse survival in recurrent rectal cancer

This study investigated the prognostic impact of serum carcinoembryonic antigen (CEA) level in recurrent rectal cancer. We reviewed 745 patients who developed recurrence after curative treatment for rectal cancer between January 2000 and December 2012. Multivariate analyses for survival revealed that age > 60 years (p = 0.005), r-CEA ≥ 5 ng/ml (p < 0.001), disease free interval (DFI) < 12 months (p < 0.001), and palliative or conservative treatment (p < 0.001) were unfavorable factors.

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:8

Enthalten in:

Oncotarget - 8(2017), 62 vom: 01. Dez., Seite 105936-105941

Sprache:

Englisch

Beteiligte Personen:

Cho, Won Kyung [VerfasserIn]
Choi, Doo Ho [VerfasserIn]
Park, Hee Chul [VerfasserIn]
Park, Won [VerfasserIn]
Yu, Jeong Il [VerfasserIn]
Park, Young Suk [VerfasserIn]
Park, Joon Oh [VerfasserIn]
Lim, Ho Yeong [VerfasserIn]
Kang, Won Ki [VerfasserIn]
Kim, Hee Cheol [VerfasserIn]
Cho, Yong Beom [VerfasserIn]
Yun, Seong Hyeon [VerfasserIn]
Lee, Woo Yong [VerfasserIn]

Links:

Volltext

Themen:

CEA
Journal Article
Rectal cancer
Recurrence
Survival

Anmerkungen:

Date Revised 20.11.2019

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.18632/oncotarget.22511

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM279487185